1 |
Arabi YM, Casaer MP, Chapman M, et al. The intensive care medicine research agenda in nutrition and metabolism[J]. Intensive Care Med, 2017, 43 (9): 1239-1256.
|
2 |
Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit[J]. Clin Nutr, 2019, 38 (1): 48-79.
|
3 |
ESICM Working Group on Gastrointestinal Function. Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines[J]. Intensive Care Med, 2017, 43 (3): 380-398.
|
4 |
中国抗癌协会肝胆肿瘤整合护理专业委员会,重庆市医学会肝胆胰外科分会,重庆市护理学会肝胆外科护理专业委员会.胆管癌患者围手术期营养支持中国专家共识(2023版)[J].中华消化外科杂志,2023,22(8):943-952.
|
5 |
Ke L, Lin J, Doig GS, et al. Actively implementing an evidence-based feeding guideline for critically ill patients (NEED): a multicenter, cluster-randomized, controlled trial[J]. Crit Care, 2022, 26 (1): 46.
|
6 |
Casaer MP, Mesotten D, Hermans G, et al. Early versus late parenteral nutrition in critically ill adults[J]. N Engl J Med, 2011, 365 (6): 506-517.
|
7 |
NUT-RIREA-2 Trial Investigators, Clinical Research in Intensive Care and Sepsis (CRICS) group. Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2)[J]. Lancet, 2018, 391 (10116): 133-143.
|
8 |
Reintam Blaser A, Malbrain ML, Starkopf J, et al. Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems[J]. Intensive Care Med, 2012, 38 (3): 384-394.
|
9 |
陈亚欧,钱春霞,朱金伟,等.动态监测肠脂肪酸结合蛋白和D-乳酸对重度胃肠损伤患者早期肠内营养失败的预测价值[J].中国急救医学,2022,42(9):753-759.
|
10 |
Kutsogiannis J, Alberda C, Gramlich L, et al. Early use of supplemental parenteral nutrition in critically ill patients: results of an international multicenter observational study[J]. Crit Care Med, 2011, 39 (12): 2691-2699.
|
11 |
Heidegger CP, Berger MM, Graf S, et al. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial[J]. Lancet, 2013, 381 (9864): 385-393.
|
12 |
Nuzzo A, Guedj K, Curac S, et al. Accuracy of citrulline, I-FABP and D-lactate in the diagnosis of acute mesenteric ischemia[J]. Sci Rep, 2021, 11 (1): 18929.
|
13 |
Blaser A, Padar M, Tang J, et al. Citrulline and intestinal fatty acid-binding protein as biomarkers for gastrointestinal dysfunction in the critically ill[J]. Anaesthesiol Intensive Ther, 2019, 51 (3): 230-239.
|
14 |
International BR. Retracted: effect of early low-calorie enteral nutrition support in critically ill patients: a systematic review and meta-analysis[J]. Biomed Res Int, 2023 (2023): 9783495.
|
15 |
Fuentes Padilla P, Martínez G, Vernooij RW, et al. Early enteral nutrition (within 48 hours) versus delayed enteral nutrition (after 48 hours) with or without supplemental parenteral nutrition in critically ill adults[J]. Cochrane Database Syst Rev, 2019, 2019 (10): CD012340.
|
16 |
郑恒宇,李嘉琪,左俊焘,等.不同喂养不耐受变化轨迹外科危重症患者预后及影响因素的多中心研究[J].中华消化外科杂志,2023,22(11):1314-1321.
|
17 |
尹朱丹,王昱,镇坷,等.早期低热量肠内营养对危重症患者预后影响的Meta分析[J/CD].中华危重症医学杂志(电子版),2023,16(3):215-222.
|
18 |
Thuijls G, van Wijck K, Grootjans J, et al. Early diagnosis of intestinal ischemia using urinary and plasma fatty acid binding proteins[J]. Ann Surg, 2011, 253 (2): 303-308.
|
19 |
Grimaldi D, Guivarch E, Neveux N, et al. Markers of intestinal injury are associated with endotoxemia in successfully resuscitated patients[J]. Resuscitation, 2013, 84 (1): 60-65.
|
20 |
Crenn P, Vahedi K, Lavergne-Slove A, et al. Plasma citrulline: a marker of enterocyte mass in villous atrophy-associated small bowel disease[J]. Gastroenterology, 2003, 124 (5): 1210-1219.
|
21 |
Sapin V, Nicolet L, Aublet-Cuvelier B, et al. Rapid decrease in plasma D-lactate as an early potential predictor of diminished 28-day mortality in critically ill septic shock patients[J]. Clin Chem Lab Med, 2006, 44 (4): 492-496.
|
22 |
Li H, Chen Y, Huo F, et al. Association between acute gastrointestinal injury and biomarkers of intestinal barrier function in critically ill patients[J]. BMC Gastroenterol, 2017, 17 (1): 45.
|
23 |
Shen LJ, Guan YY, Wu XP, et al. Serum citrulline as a diagnostic marker of sepsis-induced intestinal dysfunction[J]. Clin Res Hepatol Gastroenterol, 2015, 39 (2): 230-236.
|
24 |
Fragkos KC, Forbes A. Citrulline as a marker of intestinal function and absorption in clinical settings: a systematic review and meta-analysis[J]. United European Gastroenterol J, 2018, 6 (2): 181-191.
|